Angiotensin-converting enzyme gene polymorphism is associated with coronary heart disease in non-insulin-dependent diabetic patients evaluated for 9 years

Metabolism: Clinical and Experimental

Volumn 47, Issue 10, 1998, Pages 1258-1262

  Huang, Xiao Hong ^a   Rantalaiho, Vappu ^a   Wirta, Ole ^a   Pasternack, Amos ^a   Koivula, Timo ^a   Hiltunen, Timo P ^a   Nikkari, Tapio ^a   Lehtimäki, Terho ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY RISK; ENZYME POLYMORPHISM; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0031751842     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90333-X     Document Type: Article

References (44)

1. Schwartz CJ, Kelley JL, Valente A, et al: Pathogenesis of the atherosclerotic lesion. Diabetes Care 15:1156-1167, 1992
2. Stamler J, Vaccaro O, Neaton JD, et al: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993
3. Earle K, Walker J, Hill C, et al: Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N Engl J Med 326:673-677, 1992
4. Erdos EG, Skidgel RA: The angiotensin I-converting enzyme. Lab Invest 56:346-348, 1987
5. Morishita R, Gibbons GH, Ellison KE, et al: Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme. J Clin Invest 94:978-984, 1994
6. Daemen MJ, Lombardi DM, Bosman FT, et al: Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 68:450-456, 1991
7. Schuh JR, Blehm DJ, Frierdich GE, et al: Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits. J Clin Invest 91:1453-1458, 1993
8. Fennessy PA, Campbell JH, Campbell GR: Perindopril inhibits both the development of atherosclerosis in the cholesterol-fed rabbit and lipoprotein binding to smooth muscle cells in culture. Atherosclerosis 106:29-41, 1994
9. Chobanian AV, Haudenschild CC, Nickerson C, et al: Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 15:327-331, 1990
10. Rigat B, Hubert C, Alhenc-Gelas F, et al: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346, 1990
11. Tiret L, Rigat B, Visvikis S, et al: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197-205, 1992
12. Cambien F, Poirier O, Lecerf L, et al: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1992
13. Ruiz J, Blanche H, Cohen N, et al: Insertion/deletion polymorphism in the gene for angiotensin converting enzyme is associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 91:3662-3665, 1994
14. Ohno T, Kawazu S, Tomono S: Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism 45:218-222, 1996
15. Fujisawa T, Ikegami H, Shen GQ, et al: Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 18:983-985, 1995
16. Schmidt S, Schone N, Ritz E: Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int 47:1176-1181, 1995
17. Ringel J, Beige J, Kunz R, et al: Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension. Diabetologia 40:193-199, 1997
18. Wirta O, Pasternack A, Mustonen J, et al: Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients. Nephrol Dial Transplant 11:449-456, 1996
19. WHO Expert Committee on Diabetes Mellitus: The second report. World Health Organ Tech Rep Ser 646:1-80, 1980
20. Rose GA, Blackburn H: Cardiovascular survey methods. Geneva, Switzerland, World Health Organization, Monograph Series No. 56, 1968
21. 2+ precipitation for quantitation of high-density lipoprotein cholesterol, in Cooper GR (ed): Selected Methods of Clinical Chemistry. Washington, DC, American Association for Clinical Chemistry, 1983, pp 91-99
22. Rigat B, Hubert C, Corvol P, et al: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 20:1433, 1992
23. Odawara M, Matsunuma A, Yamashita K: Mistyping frequency of the angiotensin-converting enzyme gene polymorphism and an improved method for its avoidance. Hum Genet 100:163-166, 1997
24. Arbustini E, Grasso M, Fasani R, et al: Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. Br Heart J 74:584-591, 1995
25. Gardemann A, Weiss T, Schwartz O, et al: Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients. Circulation 92:2796-2799, 1995
26. Marian AJ, Yu QT, Workman R, et al: Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 342:1085-1086, 1993
27. Iwai N, Ohmichi N, Nakamura Y, et al: DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 90:2622-2628, 1994
28. Ohishi M, Fujii K, Minamino T, et al: A potent genetic risk factor for restenosis. Nat Genet 5:324-325, 1993
29. Hosoi M, Nishizawa Y, Kogawa K, et al: Angiotensin-converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin-dependent diabetic patients. Circulation 94: 704-707, 1996
30. Rasmussen LM, Ledet T: Aortic atherosclerosis in diabetes mellitus is associated with an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene. No relation between the polymorphism and aortic collagen content. Diabetologia 39:696-700, 1996
31. Nesto RW, Phillips RT, Kett KG, et al: Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: Assessment by exercise thallium scintigraphy. Ann Intern Med 108:170-175, 1988
32. Yusuf S, Pepine CJ, Garces C, et al: Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 340:1173-1178, 1992
33. Danser AH, Schalekamp MA, Bax WA, et al: Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 92:1387-1388, 1995
34. Diet F, Pratt RE, Berry GJ, et al: Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 94:2756-2767, 1996
35. Danser AH, Koning MM, Admiraal PJ, et al: Production of angiotensins I and II at tissue sites in intact pigs. Am J Physiol 263:H429-H437, 1992 (suppl)
36. Osterrieder W, Muller RK, Powell JS, et al: Role of angiotensin II in injury-induced neointima formation in rats. Hypertension 18:1160-1164, 1991 (suppl IV)
37. Aberg G, Ferrer P: Effects of captopril on atherosclerosis in cynomolgus monkeys. J Cardiovasc Pharmacol 15:S65-S72, 1990 (suppl)
38. Gräfe M, Auch-Schwelk W, Graf K, et al: Induction of the adhesion molecule E-selectin in human cardiac endothelial cells by angiotensin II. Circulation 88:1316, 1993 (suppl, abstr)
39. Hahn AW, Jonas U, Buhler FR, et al: Activation of human peripheral monocytes by angiotensin II. FEBS Lett 347:178-180, 1994
40. Kato H, Suzuki H, Tajima S, et al: Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens 9:17-22, 1991
41. Ridker PM, Gaboury CL, Conlin PR, et al: Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation 87:1969-1973, 1993
42. van Leeuwen RT, Kol A, Andreotti F, et al: Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells. Circulation 90:362-368, 1994
43. Powell JS, Clozel JP, Muller PK, et al: Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245:186-188, 1989
44. Laporte S, Escher E: Neointima formation after vascular injury is angiotensin II mediated. Biochem Biophys Res Commun 187: 1510-1516, 1992